Cephea Early Feasibility Study
Recruiting now · Not applicable
Conditions studied: Mitral Regurgitation
In brief
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
Key facts
- Study ID
- NCT05061004
- Run by
- Abbott Medical Devices
- People needed
- 50
- Starts
- 2022-04-28
- Expected to finish
- 2031-03-01
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner-University Medical Center Phoenix — Phoenix, Arizona, United States (enrolling)
- Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)
- University of California - Davis Medical Center — Sacramento, California, United States (enrolling)
- Los Robles Regional Medical Center — Thousand Oaks, California, United States (enrolling)
- Emory University Hospital — Atlanta, Georgia, United States (enrolling)
- Piedmont Heart Institute — Atlanta, Georgia, United States (enrolling)
- Northwestern Memorial Hospital — Chicago, Illinois, United States (enrolling)
- Ascension Via Christi Hospitals Wichita — Wichita, Kansas, United States (enrolling)
- University of Michigan - Davis Medical Center — Ann Arbor, Michigan, United States (enrolling)
- Minneapolis Heart Institute — Minneapolis, Minnesota, United States (enrolling)
- New York-Presbyterian/Columbia University Medical Center — New York, New York, United States (enrolling)
- Montefiore Medical Center - Moses Campus — The Bronx, New York, United States (enrolling)
- Atrium Health - Carolinas Medical Center — Charlotte, North Carolina, United States (enrolling)
- The Cleveland Clinic Foundation — Cleveland, Ohio, United States (enrolling)
- Allegheny General Hospital - ASRI — Pittsburgh, Pennsylvania, United States (enrolling)
- Ascension Saint Thomas — Nashville, Tennessee, United States (enrolling)
- Vanderbilt Heart & Vascular Institute — Nashville, Tennessee, United States (enrolling)
- Houston Methodist — Houston, Texas, United States (enrolling)
- Sentara Norfolk General Hospital — Norfolk, Virginia, United States (enrolling)
- Swedish Medical Center — Seattle, Washington, United States (enrolling)
- Institut de Cardiologie de Montreal — Montreal, Quebec, Canada
- IUCPQ-ULaval — Québec, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.